Department of Otorhinolaryngology, Head and Neck Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Int J Cancer. 2023 May 1;152(9):1847-1862. doi: 10.1002/ijc.34439. Epub 2023 Feb 7.
Human papillomavirus (HPV) is causally involved in the development of head and neck squamous cell carcinoma (HNSCC). The integration of HPV drives tumorigenesis through expression of oncogenic viral genes as well as genomic alterations in surrounding regions. To elucidate involvement of epigenetic dysregulation in tumorigenesis, we here performed integrated analyses of the epigenome, transcriptome and interactome using ChIP-seq, RNA-seq and Hi-C and 4C-seq for HPV(+) HNSCCs. We analyzed clinical HNSCC using The Cancer Genome Atlas data and found that genes neighboring HPV integration sites were significantly upregulated and were correlated with oncogenic phenotypes in HPV(+) HNSCCs. While we found four HPV integration sites in HPV(+) HNSCC cell line UPCI-SCC-090 through target enrichment sequencing, 4C-seq revealed 0.5 to 40 Mb of HPV-interacting regions (HPVIRs) where host genomic regions interacted with integrated HPV genomes. While 9% of the HPVIRs were amplified and activated epigenetically forming super-enhancers, the remaining non-amplified regions were found to show a significant increase in H3K27ac levels and an upregulation of genes associated with GO terms, for example, Signaling by WNT and Cell Cycle. Among those genes, ITPR3 was significantly upregulated, involving UPCI-SCC-090-specific super-enhancer formation around the ITPR3 promoter and in the 80-kb-downstream region. The knockdown of ITPR3 by siRNA or CRISPR deletions of the distant enhancer region led to a significant suppression of cell proliferation. The epigenetic activation of HPVIRs was also confirmed in other cell lines, UM-SCC-47 and UM-SCC-104. These data indicate that epigenetic activation in HPVIRs contributes, at least partially, to genesis of HPV(+) HNSCC.
人乳头瘤病毒(HPV)是头颈部鳞状细胞癌(HNSCC)发展的致病因素。HPV 的整合通过表达致癌病毒基因以及周围区域的基因组改变来驱动肿瘤发生。为了阐明表观遗传失调在肿瘤发生中的作用,我们在这里使用 ChIP-seq、RNA-seq 和 Hi-C 以及 4C-seq 对 HPV(+)HNSCC 进行了表观基因组、转录组和互作组的综合分析。我们使用癌症基因组图谱(The Cancer Genome Atlas)数据分析了临床 HNSCC,并发现 HPV 整合位点附近的基因显著上调,并与 HPV(+)HNSCC 中的致癌表型相关。虽然我们通过靶向富集测序在 HPV(+)HNSCC 细胞系 UPCI-SCC-090 中发现了四个 HPV 整合位点,但 4C-seq 揭示了 0.5 到 40Mb 的 HPV 相互作用区域(HPVIRs),其中宿主基因组区域与整合的 HPV 基因组相互作用。虽然 9%的 HPVIRs 被扩增并通过表观遗传激活形成超级增强子,但其余非扩增区域被发现 H3K27ac 水平显著增加,并且与 GO 术语相关的基因上调,例如 WNT 和细胞周期信号转导。在这些基因中,ITPR3 显著上调,涉及 UPCI-SCC-090 特异性超级增强子形成,位于 ITPR3 启动子周围和 80kb 下游区域。ITPR3 的 siRNA 敲低或远距离增强子区域的 CRISPR 缺失导致细胞增殖显著抑制。HPVIRs 的表观遗传激活也在其他细胞系 UM-SCC-47 和 UM-SCC-104 中得到证实。这些数据表明,HPVIRs 的表观遗传激活至少部分促成了 HPV(+)HNSCC 的发生。